NCT05567510 A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT05567458 A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05560399 A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05558319 NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide Status NOT_YET_RECRUITING Phase PHASE3
NCT05556343 A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy Status TERMINATED Phase PHASE2
NCT05556265 A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata Status TERMINATED Phase PHASE2
NCT05552976 A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05547490 A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis Status COMPLETED Phase N/A
NCT05546151 A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent Status COMPLETED Phase PHASE1
NCT05543629 A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT05539976 A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants Status COMPLETED Phase N/A
NCT05524857 Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP) Status TERMINATED Phase PHASE1
NCT05517837 A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants Status TERMINATED Phase EARLY_PHASE1
NCT05516537 Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments. Status RECRUITING Phase NA
NCT05502315 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT05500092 An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05498480 Study of Relatlimab in Combination With Nivolumab in Chinese Participants Status COMPLETED Phase PHASE1
NCT05496192 A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT05492123 Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer Status RECRUITING Phase PHASE2